Parkinsonism & Related Disorders

Article	Citations
Malignant Neuroleptic Syndrome in a Patient with Huntington's Disease	164
Error-based biofeedback for gait training in Parkinson's disease	96
Dual Phase 18F-FP-CIT PET in presynaptic and trans-synaptic nigrostriatal dysfunction in Multiple System Atrophy	86
APOE carrier status and cognitive outcomes after STN-DBS surgery for Parkinson’s disease.	82
A case of probable Progressive Supranuclear Palsy Frontal type (PSP-F) presenting as psychosis	79
Leveraging Telehealth and Wearables for Parkinson’s Disease: Innovative Approaches to Enhance Personalized Care	71
Effect of ND0612 Continuous Infusion on Motor Performance and Experiences of Daily Living in Patients With Parkinson’s Disease	70
Neurocognition, Cerebellar Functions and Psychiatric Features in Spinocerebellar Ataxia Type 34	53
FindPD.DaT: Development of a Novel Artificial Intelligence-driven Tool for Diagnosis of Parkinson’s Disease using Dopamine Transporter Scans	43
Perioperative quantification of MDS-UPDRS-III tremor measurements in patients with Parkinson’s Disease using accelerometry	41
Effects of an intensive, multidisciplinary rehabilitative treatment in an outpatient setting on clinical outcomes in Parkinson’s Disease: preliminary results.	41
β-Caryophyllene decreases neuroinflammation and exerts neuroprotection of dopaminergic neurons in a model of hemiparkinsonism through inhibition of the NLRP3 inflammasome	40
Association between serum lipid levels and dopamine loss in idiopathic rapid eye movement sleep behavior disorder	39
Asymmetric Parkinsonism and Ataxia with autonomic dysfunction and RBD	39
Treatment of refractory post-hypoxic myoclonus and focal epilepsy with subthalamic nuclei deep brain stimulation	39
Diet quality and prodromal Parkinson's disease probability in isolated REM sleep behavior disorder	37
Diagnosis of vascular parkinsonism: A new tool for gait hypokinesia occurring in older persons	37
Fear among patients with Parkinson's disease and repeated falls: Analysis of skin conductance responses during simulated accidents	36
A useful cognitive motor dual task paradigm in prodromal and manifest Huntington’s disease	36
Hemiatrophy-hemiparkinsonism and Poland syndrome: A causative or coincidental association?	34
Leigh-like syndrome as a presentation of biallelic variants in DNAJC30 gene with predominant putamen degeneration and limb dystonia	34
Apomorphine sublingual film for “OFF” episodes in Parkinson’s disease: analysis of baseline factors	32
Critical Appraisal of Economic Evaluation of Biomarkers Used for Screening of Dementia	32
Early onset hemichorea-parkinsonism with POLG mutation without external ophthalmoplegia responsive to pallidal DBS	31
A novel summary index derived from Kinect to evaluate the severity of postural abnormalities in patients with Parkinson’s Disease	31

White matter connectivity networks predict early dementia conversion in Parkinson’s disease	31
Chorea-Acanthocytosis: A Case Report	30
Association of Baseline Serum Urate Levels with Longitudinal General Cognition in Non-Demented Parkinson's Disease	30
Examination of cognitive function in Parkinson's disease patients with chronic kidney disease	30
“Pop-up” studies: Observational studies in Huntington disease conducted at annual family convention	30
Fibrinogen exacerbates GCase ubiquitination via ATF5-induced TRIP12 activation in Parkinson's Disease	29
Association and Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson’s Disease–related Cognitive Impairment	29
Targeting sedentary behavior decreases depressive symptoms and improves sleep in people with Parkinson’s Disease	29
Role of linagliptin, a dipeptidyl peptidase-4 inhibitor against oxidative stress and neuronal damage in experimental diabetic aging brain of female rats of different age groups.	29
Digital devices and wearable technology for quantification of freezing of gait in adolescents with pediatric movement disorders attending school	27
Establishing a framework for quality of inpatient care for Parkinson's disease: A study on inpatient medication administration	27
Integrity of Dopaminergic Terminals in the Caudate Nucleus Modulates Rest Tremor in Parkinson’s Disease	27
Is rapid eye movement sleep behavior disorder a marker of Parkinson's disease severity?	27
Relation between Clinical and Electrophysiological Correlates of Peripheral Polyneuropathy and Oral Levodopa Treatment in People with Parkinson’s Disease	27
Plasma microRNA predict cognitive decline in Parkinson's disease	26
Mitochondrial and autophagic dysfunctions of skin fibroblasts derived from pantothenate kinase-associated neurodegeneration patients carrying PANK2 mutations and the rescuing effects of allantoin	26
Assessment of SLC25A46 variants in idiopathic Parkinson's disease	26
Objective sleep enhancement in Parkinson's disease: A sham-controlled trial of low-frequency repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex	26
Evaluation of mild cognitive impairment in older patients with essential tremor	25
Cognitive impairment in REM-sleep behaviour disorder and individuals at risk of Parkinson's disease	24
Understanding microlesion and cognitive interactions in STN-DBS: A clinical perspective	24
Symptom onset lateralization and bilaterality in Parkinson's disease: Clinical implications of motor and non-motor profiles	24
Impaired sleep microarchitecture is associated with locus coeruleus degeneration in Parkinson's disease	24
Magnetic resonance spectroscopy reveals evidence of brain oxidative stress in Tourette syndrome	24
Prevalence and clinical impact of alpha-synuclein pathology in idiopathic normal pressure hydrocephalus: Insights from RT-QuIC assay	24
Hemiballistic hemi-myoclonus in Subacute Sclerosing Pan encephalitis – A novel observation	24
Cerebellum crus II cortical thickness as a cognitive brain reserve in Parkinson's disease	23
Longitudinal brain changes in Parkinson's disease with severe olfactory deficit	23
Study of 17β estradiol with neuropeptide and amyloid beta fragment on neuronal and biochemical functions in naturally menopausal aging rats	23
Early-onset Parkinson's disease, regional and national burden, and its attributable risk factors in 204 countries and regions from 1990 to 2021: Results from the global burden of disease study 2021	23
Psychometric analysis of the short form UCLA Loneliness Scale (ULS-8) in people with Parkinson's disease	23
Shotgun metagenomic profiling of the gut microbiota in Parkinson's disease dementia and dementia with Lewy bodies	23
The Elevated Risk of Dementia in Parkinson's Disease Patients Associated with Metabolic Syndrome	23
The effects of stretching in Parkinson's disease: A systematic review of randomized controlled trials	23
Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and 123I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyse	23
Machine Learning Analysis of the Interaction Between miR-155 and LRRK2 Gene Variants in Parkinson's Disease Progression	23
Huntington Disease – Update on Recent Advances and a Look Toward the Future	22
Somnolence-Related Events Over Time During Valbenazine Treatment for Chorea Associated with Huntington’s Disease	22
Efficacy of Once-Daily Valbenazine in Adults with Chorea Associated with Huntington’s Disease: Effect Size Over Time	22
Hereditary Spastic Paraparesis with SPG6 mutation: First case report from Malaysia	22
Unveiling the Complexity of Parkinson's Disease: Exploring Subtypes and Tracing its Five-Stage Natural Course	22
Association between global cognitive function and autonomic dysfunction in patients with de novo Parkinson’s disease	22
Parkinson’s Disease with Hyposmia and Dysautonomia: Does It Represent a Distinct Subtype?	22
The role of neurotrophic factors in development Parkinson's disease dementia	22
The characteristic and prognostic role of blood inflammatory markers in patients with Huntington's disease from China	22
Clinical Evaluation of Parkinson's Disease Patients Admitted to the Movement Disorders Outpatient Clinic of Istanbul Taksim Training and Research Hospital, Turkey, 2023	22
Establishing exercise habits in patients with Parkinson's disease through an exercise group model	22
Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism	22
Segmental dystonia as the prominent phenotype resulting from a MICU1 splice variant in a new Indian case	21
From writer's cramp to blepharoclonus: An atypical journey with a novel KMT2B variant	21

Motor and non-motor responses of STN DBS in early onset PLA2G6 related Parkinsonism with compound heterozygous mutation from China	21
Expert commentary: Teaching points from A young patient with spastic paraparesis and ataxia due to P102L GSS	21
Dentate calcifications with palatal tremor and facial myorhythmia in adult-onset Cerebral X-linked Adrenoleukodystrophy	21
Commentary on “The use of hypoglycemic drugs in Parkinson's disease: An updated meta-analysis of randomized controlled trials”	21
Genetic overlap between dystonia and other neurologic disorders: A study of 1,100 exomes	21
Atypical Presentation of Autosomal Recessive Cerebellar Ataxia Type I Mimicking Amyotrophic Lateral Sclerosis	21
Cystatin C as a Biomarker for the Development of Parkinson disease in Patients with Chronic Kidney Disease	20
Colony-Stimulating Factor-1 Receptor-Related Disorders in the Hispanic Population: A Report of six Families	20
Deep learning-based MRI segmentation for substantia nigra in Parkinson's disease with cognitive impairment	20
The BEACON Study: LRRK2 inhibition by BIIB122/DNL151 in participants with Pathogenic LRRK2 Variants and Parkinson’s disease	20
Augmented reality cueing for freezing of gait: Reviewing an emerging therapy	20
Protective Lifestyle Risk Factors Against Parkinson’s Disease In Sub-Saharan Africa: A Review On Current Evidence	20
A young man with progressive dysarthria, generalized slowness and memory loss	20
Dopaminergic dysfunctions instigated by Nano-formulation of Neonicotinoid pesticides in mice	20
Effect of Safinamide on Non-motor symptoms and QoL According to Sex, Age, Disease Duration and Levodopa Equivalent Daily Dose	20
On demand inhaled levodopa in Parkinson´s disease (pd) patients with device assisted therapies	20
Editorial Board	20
A late-onset neurological disorder: Is progression inevitable? Expert Commentary	19
Editorial Board	18
¿It Is Any Difference Between Directional Vs Omnidirectional Lead For Treatment In Parkinson Disease?	18
Cognitive and neuropathological contributions to gait dysfunction in Parkinson's disease	18
Editorial Board	18
Brittle dyskinesias after bilateral STN DBS: dissociation of microlesioning effect on tremor versus on dyskinesias	18
A de novo GRIA3 variant with complex hyperkinetic movement disorder in a girl with developmental delay and self-limited epilepsy	18
The distinctive functional connectivity of the cholinergic nucleus basalis of Meynert in Parkinson’s disease across different cognitive status	18
Long-term incobotulinumtoxinA treatment for chronic sialorrhea: efficacy and safety over 64 weeks	18
Machine Learning-based World Health Organization Disability Assessment Schedule for persons with Parkinson's disease	18
The MemTrax memory test for detecting and assessing cognitive impairment in Parkinson's disease	17
Single-dose intranasal administration of α-syn PFFs induce lewy neurite-like pathology in olfactory bulbs	17
Association of bilateral oophorectomy with incidence of Parkinson's disease: A systematic review and meta-analysis	17
Gerstmann-Straussler-Scheinker disease: Lessons from two new Indian kindreds	17
Diverse paths of phenotypic evolution in functional movement disorders: A longitudinal perspective	17
Differences in progressive supranuclear palsy in patients of Asian ancestry?	16
The impact of anti-inflammatory therapy on Parkinson's disease incidence: A retrospective cohort study	16
Diagnostic performance of T1-Weighted MRI gray matter biomarkers in Parkinson's disease: A systematic review and meta-analysis	16
Expanding the phenotypic and genotypic spectrum of DYT-TUBB4A with seven patients from India	16
Levodopa, homocysteine and Parkinson's disease: What's the problem?	16
Tardive dyskinesia versus tardive syndrome. What is in a name?	16
Atypical antipsychotic use and mortality risk in Parkinson disease	16
Functional movement disorders in dopa-responsive dystonia	16
Parkinson's disease risk in patients with ocular motor cranial neuropathy: a Korean population-based study	16
Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis	16
Alterations in electrochemical skin conductance as a marker of autonomic dysfunction in multiple system atrophy	16
MRI index of glymphatic system mediates the influence of locus coeruleus on cognition in Parkinson's disease	16
Genetic study of early-onset Parkinson's disease in the Malaysian population	16
Expanding the genotype-phenotype landscape of PDE10A-associated movement disorders	15
Sex differences for cognitive decline in progressive supranuclear palsy	15
Wearable sensors for assessing disease severity and progression in Progressive Supranuclear Palsy	15
Introducing Virtual Shared Medical Appointments as a Novel Treatment Platform for Functional Movement Disorders	15
ERCC4 variants causing neurodegeneration with ataxia and chorea in three siblings in Lithuanian family	15
Association between cognitive adverse effects of anticholinergic medication and development of dementia in Parkinson's disease	15
Comparative pharmacokinetics of levodopa–carbidopa intestinal gel infusion and foslevodopa–foscarbidopa continuous subcutaneous infusion therapies in advanced Parkinson's disease	15
Amplitude of low-frequency fluctuation differences in resting-state functional magnetic resonance imaging between Parkinson's disease and multiple system atrophy-parkinsonian type	15
Impact of inpatient mobility on outcomes in Parkinson's disease	15
The factors for choosing intesticular gel therapy	15
REM density in Parkinson’s disease: Effects of motor, cognitive, and autonomic function, and the impact of evening dopaminergic medication	15
Recent advances in non-Huntington's disease choreas	15
Neuropsychological studies in children with tic hyperkinesis	15
Frequency settings of subthalamic nucleus DBS for Parkinson's disease: A systematic review and network meta-analysis	15
Personality assessment with Temperament and Character Inventory in Parkinson's disease	15
Phenotypic manifestations of KIF5A Arg1007Lys mutation: A large kindred study	15
Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN) Presenting With Parkinsonism Findings: A Case Report	15
Post-COVID parkinsonism: A scoping review	15
Patients with progressive supranuclear palsy need to be seen sooner and more frequently	14
Cognitive function, psychobehavioral symptoms, and MRI features in patients with non-demented Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies	14
The role of semispinalis capitis muscles in cervical dystonia with goose-neck posture	14
Sexual dysfunction in patients with focal dystonia	14
Increased blood-derived mitochondrial DNA copy number in African ancestry individuals with Parkinson's disease	14
Correcting vertical perception to reverse Pisa syndrome in Parkinson's disease: A case report	14
MRgFUS of the nucleus ventralis intermedius in essential tremor modulates functional connectivity within the classical tremor network and beyond	14
Interaction between caffeine intake and polymorphisms of PARK16 modifies Parkinson’s Disease risk	14
Identification of the needs of patients with Parkinson’s disease through a qualitative research process	14
Spinocerebellar ataxia type 10 in a Guatemalan family: Characterization and preliminary evaluation of neurofilament light chain as a biomarker	14
The feasibility of using loss of “swallow tail sign” on 3T – susceptibility weighted MRI in diagnosis of Parkinson’s disease	14
Association between global cognitive function and autonomic dysfunction in patients with de novo Parkinson’s disease	14
Improvement of non-motor symptoms with NE3107 adjunctive to Carbidopa / Levodopa in patients with Parkinson`s disease: A Phase 2A, placebo-controlled study	14
Parkinson's disease with and without history of Agent Orange exposure: A prospective study of US Veterans	13
Spinocerebellar ataxia subtype 40: Report of a case and review of literature	13
Attainment of physiologic salivary flow rate with long-term incobotulinumtoxinA treatment for sialorrhea in Parkinson’s disease and other neurologic conditions	13
“A man with an arched back”: Expert commentary	13

Editorial Board	13
Thyroid disease in cervical dystonia	13
Altered subthalamic alpha-beta oscillations in PRKN-associated early onset Parkinson's disease in relation to off-dystonia	13
Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysis	13
Real-world effect of age on long-term effectiveness and safety of levodopa-carbidopa intestinal gel: post hoc analysis from the DUOGLOBE study	13
Analysis of GIPC1 CGG repeat expansions in essential tremor	13
Cerebellar blood perfusion is a diagnostic, but not a prognostic, marker for parkinsonian-dominant type multiple system atrophy	13
Long-term outcomes associated with istradefylline versus catechol-O-methyltransferase inhibitors in patients with Parkinson's disease: a nationwide real-world cohort study	13
Tremor is associated with familial clustering of dystonia	13
The effects of once-daily opicapone 50 mg on the pharmacokinetics of levodopa administered as carbidopa/levodopa extended-release capsules: an open-label study	13
Late-onset parkinsonism in a patient with a novel frameshift THAP1 variant	13
Seronegative basal ganglia encephalitis mimicking dementia of Lewy body	13
Reliability of remote video ratings of the scale for assessment and rating of ataxia	13
Grey matter correlates of dystonic soft signs in essential tremor	12
Comment on “Defining ‘OFF’ time in device-aided therapy criteria for Parkinson's disease: Gaps and opportunities”	12
Subjective cognitive complaints are important in PD-MCI criteria: Associations with CSF markers and cognitive decline	12
Convergence insufficiency and Parkinson's disease progression	12
Tongue strength in progressive supranuclear palsy	12
Empowering the management of early-onset Parkinson’s disease: The role of technology	12
Reply to: Transcriptomic analysis of plasma small extracellular vesicles identifies potential diagnostic biomarkers for Parkinson's disease dementia	12
Comparison of tetrabenazine, tiapride and olanzapine in Huntington's disease: a one-year French randomized multicenter study (Neuro-HD)	12
Response to levodopa in Parkinson's disease over time. A 4-year follow-up study	12
Mixture effects of dietary fatty acids on Parkinson's disease: A weighted quantile sum analysis	12
Motor band sign in a Huntington disease phenocopy	12
Ethnoracial differences for caregiving burden in Parkinson’s disease	12
Cropland associated with risk of Parkinson's disease in the northern Great Plains	12
Telomeres, REM sleep, and RBD: A link to neurodegeneration?	12
Fecal tyrosine decarboxylase and motor response complications in Parkinson's disease	12
The use of hypoglycemic drugs in Parkinson's disease: An updated meta-analysis of randomized controlled trials	12
Infrathalamic ablation in advanced Parkinson's disease: Three-year outcomes support a safe and accessible therapeutic strategy	12
A diagnostic blind spot in late-onset ataxia: missed FGF14 repeat expansion after negative genome sequencing and the risk of forced diagnostic unification	12
Dopaminergic connectivity reconfiguration in the dementia with Lewy bodies continuum	12
Editorial Board	11
Development of a screening AI model for Parkinson's disease using gait image sequences	11
A structural perspective on the interaction between glucocerebrosidase and the positive allosteric modulator BIA 28-6156	11
Differential modulation of subjective postural vertical by support-surface conditions in Parkinson’s disease with postural abnormalities	11
The use of botulinum toxin A in the treatment of hand tremor	11
Assessment of Cerebral Cortical Atrophy Using Visual Rating Scale in Patients with Functional Movement Disorder	11
Analysis of interleukin-6 levels in patients with Parkinson's disease by disease stage	11
Retinal structural changes in Parkinson's disease: differences in pRNFL thickness between GBA1-associated and idiopathic cases	11
Enhanced low beta activity in Park2-associated Parkinson’s disease	11
TorsinA-interacting protein 2 (TOR1AIP2) variants in an autosomal dominant combined dystonia-hemichorea-hemiballismus syndrome in two families	11
Usage of modern technologies like VR therapy, physio therapy along with levodopa in Young-Onset Parkinson's disease patients	11
WITHDRAWN	11
Calcium channel blockers and Parkinson's disease: A systematic review and meta-analysis	11
Challenges during prayer (namaz/salah) rituals in Muslim patients with Parkinson’s disease	11
An atypical case of head tremor	11
The influence of fatigue on motor imagery ability in people with Parkinson’s disease – preliminary study	11
MOBP gene risk variant is associated with higher cerebrospinal fluid levels of neurofilament light chain: a Barcelona PSP Registry study	11
Accelerometric quantification of MDS-UPDRS bradykinesia measurements in PD patients: A pilot study	11
Right to the Point - A Writer’s Cramp Successful Treatment	11
Magnetic Resonance Imaging Marker for the Conversion from Idiopathic Late-onset Cerebellar Ataxia to Multiple System Atrophy	11
Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for Parkinson’s disease: Three-year data from the open-label BeyoND study	11
Profile of patients with advanced Parkinson’s disease treated with Levodopa–entacapone–carbidopa intestinal gel (LECIG)	11
A Novel Missense Mutation in the Spectrin Repeat of SPTBN2 Identified in Spinocerebellar Ataxia Type 5	11
The iNPH Radscale May Better Predict Whether Ventriculoperitonal Shunting was Offered, Compared to Drain Trial Gait Variables	11
Functional movement disorder comorbidity in Parkinson's disease: A multicenter descriptive study	10
A case of levodopa responsive parkinsonism due to methanol toxicity, an impact of COVID-19 crisis	10
Structural and functional brain abnormalities in idiopathic cervical dystonia: a multimodal meta-analysis	10
Preliminary verification of a Kinect-based system for evaluating postural abnormalities in patients with Parkinson’s disease	10
Diagnosis across a cohort of “atypical” atypical and complex parkinsonism	10
Real world evidence of efficacy ad safety of subcutaneus foslevodopa/foscarbidopa infusion in advanced Parkinson disease	10
Influence of Toxic Exposure on the Age of Onset of Parkinson's Disease: An Observational and Analytical Study.	10
Developing a Female-Specific Mouse Model for Parkinson’s Disease Using a High-Sensitivity Neural Network	10
Backward leaning during gait: An underrecognized sign in Niemann-Pick type C	10
Exploring regional BOLD fluctuations to understand the pathophysiology of mild cognitive impairments in individuals with Parkinson's disease	10
Inter-muscular coherence in speed skaters with skater's cramp	10
Long-term safety of continuous levodopa/carbidopa infusion with ND0612: results from the ongoing BeyoND study	10
Comparison of voice parameters, self-assessment of speech and sialorrhea levels in Parkinson's disease patients with and without swallowing problems	10
A novel GNAL pathogenic variant leading to generalized dystonia: Immediate and sustained response to globus pallidus internus deep brain stimulation	10
Clinical progression of vascular Parkinsonism in ischemic stroke patients with metabolic syndrome	10
TMS-evoked potentials provide novel neurophysiological features of Tourette syndrome	10
Utility of clinical tests for asymmetry in Parkinson's disease and Atypical Parkinsonian disorders: the PARK-SYMM scale study.	10
Editorial Board	10
Chorea-acanthocytosis with homozygous variant of VPS13A gene concomitant with intermediate expansion of JPH3 gene: Who is the villain?	10
Real-world local field potential recordings in patients with deep brain stimulation for Parkinson's disease	10
Leucine-rich repeat kinase2 (LRRK2) associated Parkinson's disease: less vulnerable during Covid-19 pandemic?	10
Development of osteomyelitis after COVID 19 in patients with vascular parkinsonism	10
Efficacy of Probiotics for treatment of constipation in Parkinson’s patients: a systematic review and meta-analysis	10
Symptom changes with hormonal variations in genetic dystonia	10
Exploring Novel Therapeutic Approaches in Parkinson’s Disease: A Comprehensive Review	10
Demonstration of a Prototype Clinical Decision Support System for Diagnosing Parkinson’s Disease	10
Double blind, nonrandomized crossover study of active recharge biphasic deep brain stimulation for primary dystonia	10
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation	9
Nigrostriatal dysfunction in RFC1-related disorder/CANVAS	9
Update: Protective and risk factors for Parkinson disease	9
Plasma sphingolipids, dopaminergic degeneration and clinical progression in idiopathic Parkinson's disease	9
A multidisciplinary telemedicine approach for managing frailty in Parkinson's disease. A longitudinal, case-control study	9
Levodopa responsive childhood-onset generalized dystonia with diaphragmatic involvement associated with an SPTBN2 variant	9
Resting-state EEG predicts cognitive decline in a neuropathologically diagnosed longitudinal community autopsied cohort	9
Structural and functional connectomics of the olfactory system in Parkinson's disease: a systematic review	9
Association of subthalamic beta frequency sub-bands to symptom severity in patients with Parkinson's disease: A systematic review	9
Monocyte to high-density lipoprotein cholesterol ratio reflects the peripheral inflammatory state in parkinsonian disorders	9
Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's disease	9
Diagnosis of Parkinson's disease from hand drawing utilizing hybrid models	9